<DOC>
	<DOC>NCT02318212</DOC>
	<brief_summary>International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.</brief_summary>
	<brief_title>Dilapan-S / Dilasoft E-Registry in Induced Abortion</brief_title>
	<detailed_description>International, multicentre, non-interventional, observational e-registry, post market clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for cervical priming before induced abortion with regard to the number of dilators used, duration of insertion of dilators in situ and unusual complications consequent of their use.</detailed_description>
	<criteria>Intrauterine pregnancy ≥ 6 and ≤ 24 weeks gestation Patients who are capable of giving consent and sign the form Abortion being made in compliance with the Abortion Act 1967 (For England, Wales and Scotland) Clinical signs of uterine, vaginal or vulvar infection Acute bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cervical dilatation</keyword>
</DOC>